Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia
- PMID: 34254920
- PMCID: PMC8762185
- DOI: 10.2174/1570159X19666210712151556
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia
Abstract
Background: Withania somnifera (WS), also known as Ashwagandha, is commonly used in Ayurveda and other traditional medicine systems. WS has seen an increase in worldwide usage due to its reputation as an adaptogen. This popularity has elicited increased scientific study of its biological effects, including a potential application for neuropsychiatric and neurodegenerative disorders.
Objective: This review aims to provide a comprehensive summary of preclinical and clinical studies examining the neuropsychiatric effects of WS, specifically its application in stress, anxiety, depression, and insomnia.
Methods: Reports of human trials and animal studies of WS were collected primarily from the PubMed, Scopus, and Google Scholar databases.
Results: WS root and leaf extracts exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies. WS also improved symptoms of depression and insomnia, though fewer studies investigated these applications. WS may alleviate these conditions predominantly through modulation of the hypothalamic-pituitary-adrenal and sympathetic-adrenal-medullary axes, as well as through GABAergic and serotonergic pathways. While some studies link specific withanolide components to its neuropsychiatric benefits, there is evidence for the presence of additional, as yet unidentified, active compounds in WS.
Conclusion: While benefits were seen in the reviewed studies, significant variability in the WS extracts examined prevents a consensus on the optimum WS preparation or dosage for treating neuropsychiatric conditions. WS generally appears safe for human use; however, it will be important to investigate potential herb-drug interactions involving WS if used alongside pharmaceutical interventions. Further elucidation of active compounds of WS is also needed.
Keywords: Anxiety; Ashwagandha; Withania somnifera.; depression; insomnia; stress.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures


Similar articles
-
Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors.J Ethnopharmacol. 2015 Aug 2;171:264-72. doi: 10.1016/j.jep.2015.05.058. Epub 2015 Jun 9. J Ethnopharmacol. 2015. PMID: 26068424
-
Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.J Ethnopharmacol. 2021 Jan 10;264:113157. doi: 10.1016/j.jep.2020.113157. Epub 2020 Aug 9. J Ethnopharmacol. 2021. PMID: 32783987 Review.
-
Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry.Expert Rev Clin Pharmacol. 2022 Sep;15(9):1067-1080. doi: 10.1080/17512433.2022.2121699. Epub 2022 Sep 8. Expert Rev Clin Pharmacol. 2022. PMID: 36062480 Review.
-
Withania somnifera ameliorates sexual arousal and impotence in stressed sexually sluggish male rats by modulating neurotransmitters and NO/cGMP/PDE5α pathway.J Ethnopharmacol. 2024 Jan 10;318(Pt B):116971. doi: 10.1016/j.jep.2023.116971. Epub 2023 Jul 31. J Ethnopharmacol. 2024. PMID: 37532077
-
Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.J Ethnopharmacol. 2024 Apr 6;323:117699. doi: 10.1016/j.jep.2023.117699. Epub 2024 Jan 6. J Ethnopharmacol. 2024. PMID: 38185262
Cited by
-
Promoting salutogenic pathways to health through complementary and integrative health approaches.Front Psychol. 2024 Oct 2;15:1473735. doi: 10.3389/fpsyg.2024.1473735. eCollection 2024. Front Psychol. 2024. PMID: 39417020 Free PMC article.
-
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial.Nutrients. 2024 Apr 26;16(9):1293. doi: 10.3390/nu16091293. Nutrients. 2024. PMID: 38732539 Free PMC article. Clinical Trial.
-
Bioactivity-guided fractionation of Withania somnifera (L.) Dunal roots extract: evaluation of the anti-progressive potential on human Kelly neuroblastoma cell line.BMC Complement Med Ther. 2025 Jul 16;25(1):267. doi: 10.1186/s12906-025-05018-2. BMC Complement Med Ther. 2025. PMID: 40670996 Free PMC article.
-
Anti-Neuroinflammatory Effects of Adaptogens: A Mini-Review.Molecules. 2024 Feb 15;29(4):866. doi: 10.3390/molecules29040866. Molecules. 2024. PMID: 38398618 Free PMC article. Review.
-
A narrative review on inflammaging and late-onset hypogonadism.Front Endocrinol (Lausanne). 2024 Jan 17;15:1291389. doi: 10.3389/fendo.2024.1291389. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38298378 Free PMC article. Review.
References
-
- Panossian AG, Efferth T, Shikov AN, et al. 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical